Our findings revealed a downregulation of GLS, PDHA1, and FDX1 expression, and an upregulation of NLRP3, DLST, ATP7B, ATP7A, NFE2L2, DBT, and SLC31A1 in whole RA tissues. This evidence concerns the gene NFE2L2 and rheumatoid arthritis.